Clinical Trial Update: Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating efficacy and safety of IBI306 in homozygous familial hypercholesterolemia across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia Homozygous
• Lipid Metabolism Disorders
• Proprotein Convertase Subtilisin Kexin Type 9 Related Disorders

Drugs mentioned

• IBI306

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Familial Hypercholesterolemia - Homozygous, Lipid Metabolism Disorders | Phase 2, Phase 3 | Status: UNKNOWN